Cargando…

Amyloid beta-correlated plasma metabolite dysregulation in Alzheimer's disease: an untargeted metabolism exploration using high-resolution mass spectrometry toward future clinical diagnosis

INTRODUCTION: Alzheimer's disease (AD) is a leading cause of dementia, and it has rapidly become an increasingly burdensome and fatal disease in society. Despite medical research advances, accurate recognition of AD remains challenging. Epidemiological evidence suggests that metabolic abnormali...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jingzhi, Wu, Shuo, Yang, Jun, Zhang, Qun, Dong, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Aging Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338932/ https://www.ncbi.nlm.nih.gov/pubmed/37455936 http://dx.doi.org/10.3389/fnagi.2023.1189659

Ejemplares similares

Amyloid-β in Alzheimer’s disease – front and centre after all?
por: Weglinski, Caroline, et al.
Publicado: (2023)

Aβ/Amyloid Precursor Protein-Induced Hyperexcitability and Dysregulation of Homeostatic Synaptic Plasticity in Neuron Models of Alzheimer’s Disease
por: Martinsson, Isak, et al.
Publicado: (2022)

Geranylgeranylacetone Ameliorates Beta-Amyloid Toxicity and Extends Lifespan via the Heat Shock Response in Caenorhabditis elegans
por: Mossiah, Isiah, et al.
Publicado: (2022)

The role of APOE4 in Alzheimer’s disease: strategies for future therapeutic interventions
por: Hunsberger, Holly C., et al.
Publicado: (2019)

Recent High-Resolution Structures of Amyloids Involved in Neurodegenerative Diseases
por: Diaz-Espinoza, Rodrigo
Publicado: (2021)

Amyloid beta accumulations and enhanced neuronal differentiation in cerebral organoids of Dutch-type cerebral amyloid angiopathy patients
por: Daoutsali, Elena, et al.
Publicado: (2023)

Inflammation, dysregulated iron metabolism, and cardiovascular disease
por: Rosenblum, Shaina L.
Publicado: (2023)

Inflammation, Immune Senescence, and Dysregulated Immune Regulation in the Elderly
por: Shive, Carey, et al.
Publicado: (2022)

Editorial: Metabolic signaling dysregulation and cognitive impairments in aging and Alzheimer's disease, volume II
por: Ma, Tao, et al.
Publicado: (2023)

Extraversion Is Associated With Lower Brain Beta-Amyloid Deposition in Cognitively Normal Older Adults
por: Oh, Hwamee
Publicado: (2022)

Identification of miRNA–mRNA Pairs in the Alzheimer’s Disease Expression Profile and Explore the Effect of miR-26a-5p/PTGS2 on Amyloid-β Induced Neurotoxicity in Alzheimer’s Disease Cell Model
por: Xie, Tao, et al.
Publicado: (2022)

Discovering Hair Biomarkers of Alzheimer’s Disease Using High Resolution Mass Spectrometry-Based Untargeted Metabolomics
por: Su, Yu-Hsiang, et al.
Publicado: (2023)

Variant biomarker discovery using mass spectrometry-based proteogenomics
por: Reilly, Luke, et al.
Publicado: (2023)

Gut microbiota may be involved in Alzheimer’s disease pathology by dysregulating pyrimidine metabolism in APP/PS1 mice
por: Feng, Min, et al.
Publicado: (2022)

Clinical effects of novel susceptibility genes for beta-amyloid: a gene-based association study in the Korean population
por: Kim, Bo-Hyun, et al.
Publicado: (2023)

Exploring the Contribution of (Poly)phenols to the Dietary Exposome Using High Resolution Mass Spectrometry Untargeted Metabolomics
por: Li, Yuan‐Yuan, et al.
Publicado: (2022)

Beta-Hydroxybutyrate, Friend or Foe for Stressed Hearts
por: Chu, Yuxin, et al.
Publicado: (2021)

Effects of α-Lipoic Acid on Phagocytosis of Oligomeric Beta-Amyloid(1–42) in BV-2 Mouse Microglial Cells
por: Ko, Chih-Yuan, et al.
Publicado: (2022)

Inhibiting amyloid beta (1–42) peptide-induced mitochondrial dysfunction prevents the degradation of synaptic proteins in the entorhinal cortex
por: Olajide, Olayemi Joseph, et al.
Publicado: (2022)

Integration of network pharmacology and molecular docking to explore the molecular mechanism of Cordycepin in the treatment of Alzheimer’s disease
por: Ma, Xiaoying, et al.
Publicado: (2022)

Anticoagulants inhibit proteolytic clearance of plasma amyloid beta
por: Yang, Lu, et al.
Publicado: (2017)

Transcriptional and Post-Transcriptional Regulations of Amyloid-β Precursor Protein (APP) mRNA
por: Sato, Kaoru, et al.
Publicado: (2021)

Animal Models of Alzheimer’s Disease: Utilization of Transgenic Alzheimer’s Disease Models in Studies of Amyloid Beta Clearance
por: Malm, Tarja, et al.
Publicado: (2012)

Untargeted metabolite profiling on the water-soluble metabolites of edible bird’s nest through liquid chromatography-mass spectrometry
por: Tong, Shi-Ruo, et al.
Publicado: (2020)

Exploration of novel biomarkers in Alzheimer’s disease based on four diagnostic models
por: Zou, Cuihua, et al.
Publicado: (2023)

Loop diuretics association with Alzheimer’s disease risk
por: Graber-Naidich, Anna, et al.
Publicado: (2023)

Exploring the common pathogenesis of Alzheimer’s disease and type 2 diabetes mellitus via microarray data analysis
por: Ye, Xian-wen, et al.
Publicado: (2023)

Exendin-4 alleviates β-Amyloid peptide toxicity via DAF-16 in a Caenorhabditis elegans model of Alzheimer's disease
por: Song, Xiangwei, et al.
Publicado: (2022)

G-quadruplexes and associated proteins in aging and Alzheimer’s disease
por: Vijay Kumar, M. J., et al.
Publicado: (2023)

Comprehensive analysis of dysregulated circular RNAs and construction of a ceRNA network involved in the pathology of Alzheimer’s disease in a 5 × FAD mouse model
por: Sun, Ting, et al.
Publicado: (2022)

Editorial: Molecular mechanisms of Alzheimer’s disease: From top to bottom
por: Mello-Carpes, Pâmela B., et al.
Publicado: (2022)

Neuropathology of Aging in Cats and its Similarities to Human Alzheimer’s Disease
por: Sordo, Lorena, et al.
Publicado: (2021)

Friend or Foe? Defining the Role of Glutamate in Aging and Alzheimer’s Disease
por: Cox, MaKayla F., et al.
Publicado: (2022)

Exploring the combined effects of sleep apnea and APOE-e4 on biomarkers of Alzheimer’s disease
por: Turner, Arlener D., et al.
Publicado: (2023)

A system suitability testing platform for untargeted, high-resolution mass spectrometry
por: Dmitrenko, Andrei, et al.
Publicado: (2022)

Clinical outcomes of increased focal amyloid uptake in individuals with subthreshold global amyloid levels
por: Kim, Jaeho, et al.
Publicado: (2023)

Sex Differences in Large Artery Stiffness: Implications for Cerebrovascular Dysfunction and Alzheimer’s Disease
por: Kehmeier, Mackenzie N., et al.
Publicado: (2021)

Iron chelators as a therapeutic option for Alzheimer’s disease—A mini-review
por: Schreiner, Oliver Daniel, et al.
Publicado: (2023)

FAD-deficient P187S mutation of NAD(P)H:quinone oxidoreductase 1 (NQO1*2) binds and accelerates β-amyloid aggregation
por: Panja, Sudipta, et al.
Publicado: (2022)

The C. elegans Observatory: High-throughput exploration of behavioral aging
por: Kerr, Rex A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k7b7pl9ir63jr8f745ldt5l6cj